PAI-1 and HER2 interaction in advanced breast cancer disease: evidence for added benefit from trastuzumab in HER2-negative patients
暂无分享，去创建一个
G. Aravantinos | H. Kalofonos | G. Fountzilas | G. Pentheroudakis | K. Petraki | D. Pectasides | A. Batistatou | D. Bafaloukos | K. Kalogeras | P. Papakostas | D. Miliaras | I. Efstratiou | M. Bobos | A. Koumarianou | G. Karayannopoulou | M. Sotiropoulou | E. Razis | E. Galani | Georgia Gourgioti | G. Gourgioti | Mattheos Bobos